Lv1
60 积分 2023-12-06 加入
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
6天前
已完结
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
7天前
已关闭
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity
10天前
已完结
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
24天前
已完结
LB1008 KLK5/7 targeting antibody, TRIV-509, ameliorates barrier dysfunction, inflammation and itch in atopic dermatitis models
27天前
已关闭
Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
28天前
已完结
267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
1个月前
已完结
Type I interferon–related kidney disorders
1个月前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
1个月前
已完结
[Expert consensus on clinical practice of EGFR exon20 insertion detection in non-small cell lung cancer in China (2024 edition)]
1个月前
已完结
皖公网安备34019202002308
